Superb Microvascular Imaging Ultrasonography of Plantar Fasciitis
SMI
Diagnostic Performance of Superb Microvascular Imaging Ultrasonography in Plantar Fasciitis
1 other identifier
observational
60
1 country
1
Brief Summary
A prospective study will be conducted to evaluate the diagnostic performance of SMI, gray scale US, color Doppler US and Power Doppler US.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 28, 2021
CompletedFirst Submitted
Initial submission to the registry
July 16, 2021
CompletedFirst Posted
Study publicly available on registry
July 28, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 27, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 27, 2022
CompletedDecember 28, 2022
December 1, 2022
1.6 years
July 16, 2021
December 27, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Visual Analog Scale (VAS) Pain Score
The patient will be asked to indicate his/her perceived pain intensity (most commonly) along a 100 mm horizontal line. This rating is then measured from the left edge gives the VAS score. A higher score indicates greater pain intensity and lower scores indicates less pain intensity.
Each participant will be assessed only one time at the admission time to the outpatient clinic
Heel Tenderness Index (HTI)
Heel tenderness index (HTI) will be assessed by physician; based on assessing pain on palpation (0=no pain, 1=painful, 2=painful and winces, 3=painful, winces and withdraws).
Each participant will be assessed only one time at the admission time to the outpatient clinic
Foot Function Index (FFI)
This index aims to measure the impact of foot pathology on function in terms of pain, disability and activity restriction. The FFI is a self-administered index consisting of 23 items divided into 3 sub-scales.
Each participant will be assessed only one time at the admission time to the outpatient clinic
Ultrasonographic Evaluation; Superb Microvascular Imaging, GrayScale Imaging, Color Doppler Imaging, Power Doppler Imaging
Vascular blood flow images from median nerve (enterrapted in carpal tunnel) obtained with Power Doppler and Superb microvascular imaging. \[ Time Frame: Each participant will be assessed only one time at the admission time to the outpatient clinic \] Four-stage classify will be use for grading these images; Grade 0: No vascularity in MN, Grade 1: One or two focal color-encoded spots in MN, Grade 2: One linear color-encoded line or more than two focal color-encoded spots in MN, Grade 3: More than one linear color-encoded line in MN
Each participant will be assessed only one time at the admission time to the outpatient clinic
Study Arms (2)
Participants with plantar fasciitis
Participants with the diagnose of plantar fasciitis; typical anamnesis (exacerbating pain by the first steps in the morning or after rest and with prolonged standing). The emerge of local point tenderness over the heel and proximal fascia due to the pressure applied by the physician. Thickening of the plantar fascia greater than 4 mm in ultrasonographic evaluation. measurement
Volunteers who has not foot complaints.
Volunteers who were not diagnosed with Plantar Fasciitis and without foot or heel pain when taking the first steps in the morning, with plantar fascia thickness less than 4 mm, painless, symptom-free and which had no additional rheumatic disease.
Interventions
to determine whether there is a diagnostic value of SMI in Plantar Fasciitis and whether there is a superiority when compared Power Doppler and Color Doppler modalities.
Eligibility Criteria
* Patients who diagnosed as Plantar Fasciitis as the first group * Healthy participants as the second group
You may qualify if:
- Patients who diagnosed as Plantar Fasciitis
- Age between 18-45
You may not qualify if:
- History of foot trauma or surgery
- Diabetes mellitus
- Pregnancy,
- Rheumatological diseases
- For the second group:
- asymptomatic foot,
- no previous trauma or surgery on foot,
- no history of systemic inflammatory disorders.
- History of foot trauma or surgery
- Diabetes mellitus
- Pregnancy,
- Rheumatological diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nigde Omer Halisdemir University
Niğde, 51700, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ender Salbas, MD
Omer Halisdemir University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Physical Medicine & Rehabilitation Specialist, MD
Study Record Dates
First Submitted
July 16, 2021
First Posted
July 28, 2021
Study Start
May 28, 2021
Primary Completion
December 27, 2022
Study Completion
December 27, 2022
Last Updated
December 28, 2022
Record last verified: 2022-12
Data Sharing
- IPD Sharing
- Will not share
We do not want to share IPD with any researchers.